US FDA's Consumer Health Oversight Absent From Appropriators’ Request For COVID-19 Assessment
At 90 And Counting, Will Supplement Warnings Merit Mention In Response?
Executive Summary
House appropriators don’t mention the consumer health market in requesting a report on FDA’s response to COVID-19, but the agency’s frequent warnings about products marketed with unlawful claims could merit mentioning. Encouraging accelerated production of hand sanitizers while also ensuring the additional supplies are safe is another component of its COVID-19 response that could be covered in an assessment of its response to the pandemic.